SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012896
Filing Date
2023-08-02
Accepted
2023-08-02 16:01:37
Documents
79
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20230630x10q.htm   iXBRL 10-Q 2368250
2 EX-10.1 icpt-20230630xex10d1.htm EX-10.1 132102
3 EX-31.1 icpt-20230630xex31d1.htm EX-31.1 9878
4 EX-31.2 icpt-20230630xex31d2.htm EX-31.2 9861
5 EX-32.1 icpt-20230630xex32d1.htm EX-32.1 10341
  Complete submission text file 0001558370-23-012896.txt   10022875

Data Files

Seq Description Document Type Size
6 EX-101.SCH icpt-20230630.xsd EX-101.SCH 54319
7 EX-101.CAL icpt-20230630_cal.xml EX-101.CAL 74751
8 EX-101.DEF icpt-20230630_def.xml EX-101.DEF 231946
9 EX-101.LAB icpt-20230630_lab.xml EX-101.LAB 493135
10 EX-101.PRE icpt-20230630_pre.xml EX-101.PRE 396291
73 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20230630x10q_htm.xml XML 2051307
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 231135402
SIC: 2834 Pharmaceutical Preparations